
    
      A full description of the patient registry can be found in the paper titled: Safety and
      Clinical Outcomes of an Equine-derived Heptavalent Botulinum Antitoxin Treatment for
      Confirmed or Suspected Botulism in the United States. Richardson JS, Parrera GS, Astacio H,
      Sahota H, Anderson DM, Hall C, Babinchak T. Clin Infect Dis. 2019 Apr 15;70(9):1950-1957.
    
  